Hematology TimesPredicting neurotoxicity after CAR T-cell therapyOctober 12, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesTeam identifies genetic drivers of DLBCLOctober 10, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsObinutuzumab edges out rituximab for PFS in follicular lymphomaOctober 6, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesNewer blood cancer drugs may not improve OS, QOLOctober 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Hematology TimesSperm banking may be underused by young cancer patientsOctober 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesDrug receives breakthrough designation for HLOctober 3, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Hematology TimesDoc advocates depression screening for cancer patientsOctober 1, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsAdding bortezomib to R-CHOP didn’t improve survival in diffuse large B-cell lymphomaSeptember 29, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology TimesMaintenance will be a new standard in MCL, doc saysSeptember 29, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesRepresentation in cancer clinical trialsSeptember 27, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCancer patients want info about marijuanaSeptember 26, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesEC expands approval of obinutuzumab in FLSeptember 23, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsFDA grants accelerated approval to copanlisib for relapsed follicular lymphomaSeptember 20, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesTeam creates guidelines on CAR T-cell-related toxicitySeptember 20, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesTrials of atezolizumab placed on partial holdSeptember 19, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
